Alnylam Pharmaceuticals
ALNY
#622
Rank
โ‚ฌ30.91 B
Marketcap
239,69ย โ‚ฌ
Share price
-1.16%
Change (1 day)
38.38%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company